0001181431-12-047608.txt : 20120827
0001181431-12-047608.hdr.sgml : 20120827
20120827213046
ACCESSION NUMBER: 0001181431-12-047608
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120823
FILED AS OF DATE: 20120827
DATE AS OF CHANGE: 20120827
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Price Ben Gil
CENTRAL INDEX KEY: 0001417915
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14895
FILM NUMBER: 121058241
MAIL ADDRESS:
STREET 1: 801 INSPIRATION LANE
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc.
CENTRAL INDEX KEY: 0000873303
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 930797222
STATE OF INCORPORATION: OR
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3450 MONTE VILLA PARKWAY
STREET 2: SUITE 101
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 425-354-5038
MAIL ADDRESS:
STREET 1: 3450 MONTE VILLA PARKWAY
STREET 2: SUITE 101
CITY: BOTHELL
STATE: WA
ZIP: 98021
FORMER COMPANY:
FORMER CONFORMED NAME: Sarepta Therapuetics, Inc.
DATE OF NAME CHANGE: 20120712
FORMER COMPANY:
FORMER CONFORMED NAME: AVI BIOPHARMA INC
DATE OF NAME CHANGE: 19980930
FORMER COMPANY:
FORMER CONFORMED NAME: ANTIVIRALS INC
DATE OF NAME CHANGE: 19970123
4
1
rrd354462.xml
X0306
4
2012-08-23
0
0000873303
Sarepta Therapeutics, Inc.
SRPT
0001417915
Price Ben Gil
3450 MONTE VILLA PARKWAY, SUITE 101
BOTHELL
WA
98021
1
0
0
0
Common Stock
2012-08-23
4
A
0
833
0
A
33830
D
Stock Option (Right to Buy)
10.08
2012-08-23
4
A
0
5000
0
A
2022-08-23
Common Stock
5000
5000
D
Grant of restricted stock, which shall vest in full on the earlier of (i) the anniversary date of the grant and (ii) the date of the 2013 annual meeting of shareholders.
The number of shares reported reflects the 1-for-6 reverse stock split of the common stock of the Issuer effective as of July 11, 2012.
Option shall vest in full on the earlier of (i) the anniversary date of the grant and (ii) the date of the 2013 annual meeting of shareholders.
/s/ Michael Jacobsen, as Attorney-in-Fact for Ben Gil Price
2012-08-27